MobileSmith, Inc. (MOST) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MobileSmith, Inc. (MOST) trades at $2.01. MobileSmith, Inc. is a healthcare software company specializing in cloud-based applications designed to enhance patient-provider communication. Founded in 1993, the company focuses on improving healthcare delivery through innovative technology solutions. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for MOST: MOST does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MOST against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MOST: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →MobileSmith, Inc. (MOST) Healthcare & Pipeline Overview
MobileSmith, Inc. leverages cloud-based technology to provide innovative software solutions for the healthcare sector, enhancing patient adherence and communication while addressing emerging challenges such as COVID-19 management.
What Is the Investment Thesis for MOST?
MobileSmith, Inc. operates in a niche segment of the healthcare information services industry, focusing on software solutions that enhance patient adherence and communication. The company’s cloud-based applications, particularly in response to the COVID-19 pandemic, represent significant growth catalysts. Key value drivers include the increasing demand for digital healthcare solutions, the expansion of telehealth services, and the ongoing need for effective patient management tools. With a gross margin of 52.2%, MobileSmith demonstrates operational efficiency, although its current negative profit margin of -898.2% indicates challenges in achieving profitability. As the healthcare sector increasingly adopts technology-driven solutions, MobileSmith is well-positioned to capitalize on these trends, provided it can navigate its current financial hurdles and expand its market presence.
Based on FMP financials and quantitative analysis
MOST Key Highlights
Gross margin of 52.2% indicates strong operational efficiency relative to industry standards.
- Negative profit margin of -898.2% highlights significant challenges in achieving profitability.
- Company employs a small team of 24, allowing for agile decision-making and innovation.
- Cloud-based applications are increasingly in demand, particularly in response to the COVID-19 pandemic.
- Established in 1993, MobileSmith has a long history in the healthcare technology sector.
Who Are MOST's Competitors?
MOST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BSTG Biostage, Inc. | $4.03 | +0.75% | $57.8M | 44 |
| EEOIF Elegance Optical International Holdings Limited | $0.07 | +0.00% | $63.4M | 46 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| HITC Healthcare Integrated Technologies, Inc. | $0.29 | +0.00% | $52.8M | 38 |
| HRPMF Herantis Pharma Oyj | $3.51 | +0.00% | $59.5M | 44 |
| VEEV Veeva Systems Inc. | $250.53 | -0.19% | $40.7B | 88 |
| GEHC GE HealthCare Technologies Inc. | $74.45 | -0.23% | $33.6B | 61 |
| PMCUF Pro Medicus Limited | $139.96 | +1.55% | $14.6B | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MOST's Key Strengths?
Innovative cloud-based applications tailored for healthcare.
- Strong gross margin indicating operational efficiency.
- Established presence in the healthcare technology sector since 1993.
What Are MOST's Weaknesses?
Negative profit margin indicating financial challenges.
- Limited employee base may impact scalability.
- Dependence on the U.S. market for revenue.
What Could Drive MOST Stock Higher?
Continued rollout of COVID-19 management applications as healthcare providers adapt to ongoing pandemic challenges.
- Development of new features for existing applications to enhance patient engagement and adherence.
- Expansion of partnerships with healthcare organizations to broaden market reach.
What Are the Key Risks for MOST?
Intense competition from larger healthcare technology firms could impact market share.
- Financial challenges indicated by negative profit margins may hinder growth initiatives.
- Regulatory changes in healthcare technology could affect operational compliance.
What Are the Growth Opportunities for MOST?
- Growth opportunity 1: The increasing adoption of telehealth services presents a significant growth opportunity for MobileSmith. The global telehealth market is projected to reach $559.52 billion by 2027, growing at a CAGR of 38.2%. MobileSmith's cloud-based applications can enhance telehealth offerings by improving patient adherence and communication, positioning the company to capture a share of this expanding market.
- Growth opportunity 2: The ongoing demand for effective COVID-19 management solutions provides an immediate growth driver for MobileSmith. As organizations continue to navigate the pandemic's impact, the need for tools like COVIDClear will remain critical. This market segment is expected to grow as healthcare providers seek to implement long-term solutions for workforce health monitoring, potentially increasing MobileSmith's revenue streams.
- Growth opportunity 3: The healthcare industry's shift towards value-based care presents an opportunity for MobileSmith to enhance its product offerings. By integrating analytics and reporting features into its applications, the company can provide healthcare providers with insights that improve patient outcomes and reduce costs. This aligns with the industry's focus on improving care quality, which could lead to increased adoption of MobileSmith's solutions.
- Growth opportunity 4: Expansion into new geographic markets could drive growth for MobileSmith. As healthcare systems worldwide increasingly adopt digital solutions, MobileSmith can leverage its expertise to enter international markets, particularly in regions with growing healthcare technology needs. This could diversify revenue sources and mitigate risks associated with reliance on the U.S. market.
- Growth opportunity 5: Partnerships with healthcare organizations and technology providers could enhance MobileSmith's market presence. Collaborating with established players in the healthcare sector could facilitate access to new customers and distribution channels, accelerating growth and enhancing the company's competitive positioning.
What Threats Does MOST Face?
- Intense competition from established healthcare technology companies.
- Rapid technological advancements may outpace product development.
- Regulatory changes in the healthcare sector could impact operations.
What Are MOST's Competitive Advantages?
- Specializes in cloud-based solutions tailored for the healthcare sector.
- Established brand with a history dating back to 1993.
- Focus on enhancing patient-provider communication through innovative technology.
- Ability to adapt quickly to emerging healthcare challenges, such as COVID-19.
What Does MOST Do?
MobileSmith, Inc., incorporated in 1993 and headquartered in Raleigh, North Carolina, develops software applications tailored for the healthcare industry in the United States. Originally known as Smart Online, Inc., the company has evolved to focus on creating a cloud-based ecosystem that integrates various healthcare technologies. MobileSmith's product suite includes the PeriOp Patient Adherence application, which offers an EMR-integrated mobile platform for pre and postoperative instructions, facilitating a two-way communication process between patients and healthcare providers. Additionally, the company has developed COVID Response Mobile Apps to assist hospitals in addressing communication challenges during the COVID-19 pandemic, along with COVIDClear, an application designed to assess and track the COVID-19 status of the workforce. With a small team of 24 employees, MobileSmith aims to improve healthcare delivery and patient engagement through its innovative solutions, positioning itself as a key player in the healthcare information services sector.
What Products and Services Does MOST Offer?
- Develops cloud-based software applications for the healthcare industry.
- Offers EMR integrated mobile applications for patient adherence.
- Provides COVID-19 management solutions for healthcare providers.
- Facilitates two-way communication between patients and healthcare providers.
- Supports hospitals in addressing COVID-19 communication challenges.
- Tracks and assesses workforce COVID-19 status through dedicated applications.
How Does MOST Make Money?
- Generates revenue through the sale of software licenses for healthcare applications.
- Offers subscription-based services for ongoing access to cloud-based solutions.
- Provides custom development services for specific healthcare needs.
- Engages in partnerships with healthcare organizations for joint product offerings.
What Industry Does MOST Operate In?
The healthcare information services industry is experiencing rapid growth, driven by the increasing adoption of digital health solutions and the need for improved patient engagement. The COVID-19 pandemic has accelerated the demand for telehealth services and mobile applications, creating opportunities for companies like MobileSmith. As healthcare providers seek innovative ways to manage patient communications and enhance care delivery, competition is intensifying among software developers. MobileSmith's focus on cloud-based solutions positions it favorably within this evolving landscape, although it faces competition from established players and emerging startups.
Who Are MOST's Key Customers?
- Healthcare providers seeking to enhance patient engagement.
- Hospitals and clinics looking for COVID-19 management tools.
- Healthcare organizations implementing EMR systems.
- Patients requiring mobile access to healthcare information.
Insider Activity
The most recent 11 insider filings for MobileSmith, Inc. break down as 0 sales and 11 purchases. On net that is roughly 2.2M shares acquired (about $4.4M) — insiders putting money in tends to read as conviction.
Key Financial Metrics
Return on equity for MobileSmith, Inc. stands at 225.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.12 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
MobileSmith, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Raleigh, US. The company is led by CEO Jerry Lepore. MOST has traded publicly since 2013.
MOST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Innovative cloud-based applications tailored for healthcare.
- Strong gross margin indicating operational efficiency.
- Established presence in the healthcare technology sector since 1993.
- Upcoming: Continued rollout of COVID-19 management applications as healthcare providers adapt to ongoing pandemic challenges.
Bear Case
- Negative profit margin indicating financial challenges.
- Limited employee base may impact scalability.
- Dependence on the U.S. market for revenue.
- Potential: Intense competition from larger healthcare technology firms could impact market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
MOST Latest News
-
Stocks That Hit 52-Week Highs On Friday
· Dec 13, 2019
MOST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MOST.
Price Targets
Wall Street price target analysis for MOST.
MOST MoonshotScore
What does this score mean?
The MoonshotScore rates MOST 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Jerry Lepore
CEO
Jerry Lepore has extensive experience in the technology sector, particularly in software development and healthcare solutions. He has held various leadership roles throughout his career, focusing on innovation and strategic growth. Jerry's educational background includes a degree in Computer Science, which has equipped him with the technical knowledge necessary to lead MobileSmith effectively.
Track Record: Under Jerry's leadership, MobileSmith has developed a suite of applications that address critical healthcare needs, particularly during the COVID-19 pandemic. His strategic decisions have positioned the company to leverage emerging market trends and enhance its product offerings.
MOST OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These companies may have less stringent reporting requirements, leading to varying levels of transparency and investor information.
- OTC Tier: OTC Other
- Lower liquidity can result in higher volatility and trading difficulties.
- Less stringent reporting requirements may lead to less transparency.
- Potential for increased regulatory scrutiny as the company grows.
- Review recent financial statements and filings.
- Assess the company's competitive position within the healthcare sector.
- Evaluate management's track record and strategic vision.
- Investigate any legal or regulatory issues affecting the company.
- Monitor market trends impacting the healthcare technology landscape.
- Established history since 1993 in the healthcare technology sector.
- Development of innovative applications addressing current healthcare needs.
- Engagement with healthcare providers and organizations for product validation.
What Investors Ask About MobileSmith, Inc. (MOST) — Healthcare
What does MobileSmith, Inc. do?
MobileSmith, Inc. develops cloud-based software applications for the healthcare industry, focusing on improving patient-provider communication and adherence. Key products include PeriOp Patient Adherence, which integrates with EMR systems, and COVID Response Mobile Apps that address communication challenges during the pandemic.
What do analysts say about MOST stock?
Analysts generally view MobileSmith, Inc. as a company with potential due to its innovative healthcare solutions, although concerns about its financial performance persist. Key metrics such as its negative profit margin and gross margin of 52.2% indicate both challenges and operational efficiency, respectively.
What are the main risks for MOST?
MobileSmith, Inc. faces several risks, including intense competition from larger firms in the healthcare technology sector, ongoing financial challenges reflected in its negative profit margin, and potential regulatory changes that could impact its operations and compliance requirements.
What are the key factors to evaluate for MOST?
Evaluate MOST on fundamentals, analyst consensus, and risk factors. MobileSmith, Inc. operates in a niche segment of the healthcare information services industry, focusing on software solutions that enhance patient adherence and communication. Not financial advice.
How frequently does MOST data refresh on this page?
MOST's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MOST's recent stock price performance?
MobileSmith, Inc. (MOST) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative cloud-based applications tailored for healthcare. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MOST overvalued or undervalued right now?
MobileSmith, Inc. (MOST) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MOST before investing?
Before investing in MobileSmith, Inc. (MOST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial performance is subject to fluctuation and uncertainty due to market conditions and operational challenges.